IONTOX’s comprehensive cytotoxicity screening studies aim to identify the EC50/ lowest observed adverse effect concentration. Most of our screening assays utilize fluorescence or luminescence analysis to deliver % cytotoxic or viable cells. Cell viability can further be assessed by measuring the amount of ATP. To get more information, visit our website today!
Sponsorship in April 2024
There is no data, please login to become a sponsor.
